Literature DB >> 2889359

Regulation of guanylate cyclase by atrial natriuretic factor and the role of cyclic GMP in vasodilation.

F Murad1, D C Leitman, B M Bennett, C Molina, S A Waldman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 2889359     DOI： 10.1097/00000441-198709000-00003

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN： 0002-9629            Impact factor:   2.378


× No keyword cloud information.
  6 in total

1.  Atriopeptin inhibition of thrombin-mediated changes in the morphology and permeability of endothelial monolayers.

Authors:  D A Baron; C E Lofton; W H Newman; M G Currie
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

2.  Restoring soluble guanylyl cyclase expression and function blocks the aggressive course of glioma.

Authors:  Haifeng Zhu; Jessica Tao Li; Fang Zheng; Emil Martin; Alexander Y Kots; Joshua S Krumenacker; Byung-Kwon Choi; Ian E McCutcheon; Norman Weisbrodt; Oliver Bögler; Ferid Murad; Ka Bian
Journal:  Mol Pharmacol       Date:  2011-09-09       Impact factor: 4.436

3.  Chronic blockade of endogenous atrial natriuretic polypeptide (ANP) by monoclonal antibody against ANP accelerates the development of hypertension in spontaneously hypertensive and deoxycorticosterone acetate-salt-hypertensive rats.

Authors:  H Itoh; K Nakao; M Mukoyama; T Yamada; K Hosoda; G Shirakami; N Morii; A Sugawara; Y Saito; S Shiono
Journal:  J Clin Invest       Date:  1989-07       Impact factor: 14.808

4.  Regional haemodynamic effects of depressor neuropeptides in conscious, unrestrained, Long Evans and Brattleboro rats.

Authors:  S M Gardiner; A M Compton; T Bennett
Journal:  Br J Pharmacol       Date:  1988-09       Impact factor: 8.739

Review 5.  Cardiac natriuretic peptides.

Authors:  Jens P Goetze; Benoit G Bruneau; Hugo R Ramos; Tsuneo Ogawa; Mercedes Kuroski de Bold; Adolfo J de Bold
Journal:  Nat Rev Cardiol       Date:  2020-05-22       Impact factor: 32.419

6.  Nitric Oxide-cGMP Pathway Modulation in an Experimental Model of Hypoxic Pulmonary Hypertension.

Authors:  Melanie Reinero; Maurice Beghetti; Piergiorgio Tozzi; Ludwig K von Segesser; Michele Samaja; Giuseppina Milano
Journal:  J Cardiovasc Pharmacol Ther       Date:  2021-05-08       Impact factor: 2.457
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.